Early onset of efficacy with erenumab in patients with episodic and chronic migraine

Early onset of efficacy with erenumab in patients with episodic and chronic migraine

Abstract Background Subcutaneous erenumab reduced monthly migraine days and increased the likelihood of achieving a ≥ 50% reduction at all monthly assessment points tested in 2 pivotal trials in episodic migraine (EM) and chronic migraine (CM). Early efficacy of migraine preventive medications is an...

Full description

Bibliographic Details
Main Authors: Todd Schwedt, Uwe Reuter, Stewart Tepper, Messoud Ashina, David Kudrow, Gregor Broessner, Guy P. Boudreau, Peter McAllister, Thuy Vu, Feng Zhang, Sunfa Cheng, Hernan Picard, Shihua Wen, Joseph Kahn, Jan Klatt, Daniel Mikol
Format: Article
Language:English
Published: BMC 2018-10-01
Series:The Journal of Headache and Pain
Subjects:
Erenumab
Chronic migraine
Episodic migraine
Efficacy
Migraine preventive medication
Onset of efficacy
Online Access:http://link.springer.com/article/10.1186/s10194-018-0923-6

Internet

http://link.springer.com/article/10.1186/s10194-018-0923-6

Similar Items